Comparison of dose-time-fractionation schemes in non-oat cell lung cancer
Journal Article
·
· Cancer; (United States)
DOI:https://doi.org/10.1002/1097-0142(19810901)48:5<1127::AID-CNCR2820480514>3.0.CO;2-9·
OSTI ID:6288520
A series of 205 patients with inoperable, non-oat cell carcinoma of the lung were treated with three different dose-fractionation schedules. Fifty-six patients received 5000 rads in 25 fractions over five weeks (continuous, A); 79 patients received 2000 rads in five fractions over five days, with two weeks' rest, followed by 2000 rads in five fractions over five days (split-course, B); 70 patients received 3000 rads in 10 fractions over two weeks, followed by three weeks' rest and another 3000 rads (split-course, C). The 24-month survival was 33% for A, 15% for B and 25% for C. The split course was better tolerated and radiation fibrosis was dose-related.
- Research Organization:
- Univ. of Texas, Galveston
- OSTI ID:
- 6288520
- Journal Information:
- Cancer; (United States), Journal Name: Cancer; (United States) Vol. 48:5; ISSN CANCA
- Country of Publication:
- United States
- Language:
- English
Similar Records
Patterns of tumor recurrence after definitive irradiation for inoperable non-oat cell carcinoma of the lung. [/sup 60/Co on photons]
Prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat-cell carcinoma of the lung
Impact of irradiation technique and tumor extent in tumor control and survival of patients with unresectable non-oat cell carcinoma of the lung - report by the Radiation Therapy Oncology group
Journal Article
·
Fri Aug 01 00:00:00 EDT 1980
· Int. J. Radiat. Oncol., Biol. Phys.; (United States)
·
OSTI ID:5007319
Prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat-cell carcinoma of the lung
Journal Article
·
Sun Jun 01 00:00:00 EDT 1980
· Cancer; (United States)
·
OSTI ID:5179366
Impact of irradiation technique and tumor extent in tumor control and survival of patients with unresectable non-oat cell carcinoma of the lung - report by the Radiation Therapy Oncology group
Journal Article
·
Wed Sep 15 00:00:00 EDT 1982
· Cancer (Philadelphia); (United States)
·
OSTI ID:6566498
Related Subjects
550603 -- Medicine-- External Radiation in Therapy-- (1980-)
560151* -- Radiation Effects on Animals-- Man
62 RADIOLOGY AND NUCLEAR MEDICINE
63 RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT.
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BIOLOGICAL EFFECTS
BIOLOGICAL RADIATION EFFECTS
BODY
BREATH
CARCINOMAS
COBALT 60
COBALT ISOTOPES
DIGESTIVE SYSTEM
DISEASES
DOSE-RESPONSE RELATIONSHIPS
DOSES
ELECTROMAGNETIC RADIATION
ESOPHAGUS
FIBROSIS
FRACTIONATED IRRADIATION
INFLAMMATION
INTERMEDIATE MASS NUCLEI
INTERNAL CONVERSION RADIOISOTOPES
IONIZING RADIATIONS
IRRADIATION
ISOMERIC TRANSITION ISOTOPES
ISOTOPES
LUNGS
MEDICINE
MINUTES LIVING RADIOISOTOPES
NEOPLASMS
NUCLEAR MEDICINE
NUCLEI
ODD-ODD NUCLEI
ORGANS
PATHOLOGICAL CHANGES
PATIENTS
RADIATION DOSES
RADIATION EFFECTS
RADIATIONS
RADIOINDUCTION
RADIOISOTOPES
RADIOLOGY
RADIOTHERAPY
RESPIRATORY SYSTEM
SIDE EFFECTS
SURVIVAL TIME
SYMPTOMS
THERAPY
X RADIATION
YEARS LIVING RADIOISOTOPES
560151* -- Radiation Effects on Animals-- Man
62 RADIOLOGY AND NUCLEAR MEDICINE
63 RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT.
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BIOLOGICAL EFFECTS
BIOLOGICAL RADIATION EFFECTS
BODY
BREATH
CARCINOMAS
COBALT 60
COBALT ISOTOPES
DIGESTIVE SYSTEM
DISEASES
DOSE-RESPONSE RELATIONSHIPS
DOSES
ELECTROMAGNETIC RADIATION
ESOPHAGUS
FIBROSIS
FRACTIONATED IRRADIATION
INFLAMMATION
INTERMEDIATE MASS NUCLEI
INTERNAL CONVERSION RADIOISOTOPES
IONIZING RADIATIONS
IRRADIATION
ISOMERIC TRANSITION ISOTOPES
ISOTOPES
LUNGS
MEDICINE
MINUTES LIVING RADIOISOTOPES
NEOPLASMS
NUCLEAR MEDICINE
NUCLEI
ODD-ODD NUCLEI
ORGANS
PATHOLOGICAL CHANGES
PATIENTS
RADIATION DOSES
RADIATION EFFECTS
RADIATIONS
RADIOINDUCTION
RADIOISOTOPES
RADIOLOGY
RADIOTHERAPY
RESPIRATORY SYSTEM
SIDE EFFECTS
SURVIVAL TIME
SYMPTOMS
THERAPY
X RADIATION
YEARS LIVING RADIOISOTOPES